Pseudomyxoma peritonei--experience from a tertiary referral centre
1Department of Obstetrics and Gynecology, Women's Cancer Center, University of Minnesota, Minneapolis.
Abstract:
Pseudomyxoma peritonei is a clinical diagnosis of massive abdominal swelling by a gelatinous material, produced usually from an ovarian or appendiceal primary. It is a rare entity that is usually histologically benign but behaves clinically in a malignant fashion with recurrent growth, although not demonstrating histological stromal invasion. The disease remains localized to the peritoneal cavity and the clinical course is one of repeated episodes of intestinal obstruction caused by extrinsic compression that seem only to be relieved by surgical debulking. Variable responses have been obtained with adjuvant chemo-, radio- and immunotherapy, but these isolated responses are unable to be reproduced and so there is no accepted adjuvant treatment for this disease.
Insights
Pseudomyxoma peritonei causes abdominal swelling from gelatinous material, often from ovarian or appendiceal tumors. This rare condition, though histologically benign, behaves aggressively, requiring surgical debulking for intestinal obstruction relief.
Area of Science:
- Oncology
- Gastroenterology
- Pathology
Background:
- Pseudomyxoma peritonei is a rare condition characterized by gelatinous ascites.
- It typically originates from appendiceal or ovarian mucinous neoplasms.
- The disease presents as massive abdominal distension due to tumor spread within the peritoneal cavity.
Purpose of the Study:
- To describe the clinical diagnosis, behavior, and treatment challenges of pseudomyxoma peritonei.
- To highlight the discrepancy between histological benignity and clinical malignancy.
- To review the efficacy of various adjuvant therapies.
Main Methods:
- Clinical case review and literature synthesis.
- Histopathological analysis of pseudomyxoma peritonei.
- Evaluation of treatment outcomes for surgical debulking and adjuvant therapies.
Main Results:
- Pseudomyxoma peritonei is characterized by recurrent growth within the peritoneum, causing intestinal obstruction.
- Histologically, the tumors are often benign but exhibit malignant clinical behavior without stromal invasion.
- Adjuvant treatments including chemotherapy, radiotherapy, and immunotherapy have shown variable and unreproducible responses.
Conclusions:
- Pseudomyxoma peritonei necessitates surgical debulking to manage intestinal obstruction.
- There is currently no universally accepted or consistently effective adjuvant treatment for pseudomyxoma peritonei.
- Further research is needed to identify reproducible and effective adjuvant therapies.
More Related Videos
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
09:19Culture and Imaging of Ex Vivo Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens
Published on: December 9, 2022